<DOC>
	<DOCNO>NCT00138255</DOCNO>
	<brief_summary>The purpose study see MMR chickenpox vaccine work well premature infant child carry full term . A group child carry full-term matched age , sex , race use comparison .</brief_summary>
	<brief_title>Responses Premature Infants Measles-Mumps-Rubella ( MMR ) Varicella Vaccines</brief_title>
	<detailed_description>The purpose study see MMR chickenpox vaccine work well premature infant child carry full term . A group child carry full-term matched age , sex , race use comparison . Extremely premature infant ( born &lt; 28-30 week gestation ) low antibody responses full-term infant several vaccine give postnatal age recommend full term infant . We propose evaluate immunogenicity varicella mumps-measles-rubella ( MMR ) vaccine relatively healthy 15 month-old child bear &lt; 29 week gestation . This phase IV , observational study 2 study arm 16 infant . The first group enroll infants 9-12 month old born premature ( &lt; 29 week gestation ) . The second group match sex , race , postnatal age , full term ( &gt; = 37 week gestation ) birth . Infants vaccinate visit 1 post-vaccine serology draw visit 2 ( 4 6 week visit 1 ) .</detailed_description>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Rubella</mesh_term>
	<mesh_term>Chickenpox</mesh_term>
	<mesh_term>Herpes Zoster</mesh_term>
	<criteria>1 . Premature infant &lt; 29 week gestation birth term infant &gt; = 37 week gestation birth . 2 . Postnatal age &lt; 16 month , 0 day . 3 . Has yet receive MMR varicella vaccine . ( There restriction administration vaccine time MMR/varicella vaccination . ) 4 . Parental permission . 5 . Agreement primary care pediatrician/ health care provider . 6 . Receives primary pediatric care within approximate 25mile radius University Rochester . 7 . Healthy status enrollment . 1 . Known immunodeficiency . 2 . Systemic corticosteroid therapy time MMR/varicella vaccination . 3 . Requiring oxygen therapy . 4 . Clinically significant finding review medical history physical exam determine investigator subinvestigator sufficient exclusion . 5 . Any condition determine investigator would interfere evaluation vaccine potential health risk subject .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>16 Months</maximum_age>
	<verification_date>May 2005</verification_date>
</DOC>